Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory R Pond

Showing results (151-160 of 255) with videos related to

Pageof 26
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2005
Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: a Princess Margaret Hospital phase II consortium studySébastien J Hotte, Eric W Winquist, Elizabeth Lamont, et al.
Gynecologic Oncology|June 1, 2007
UCN-01 in combination with topotecan in patients with advanced recurrent ovarian cancer: a study of the Princess Margaret Hospital Phase II consortiumStephen Welch, Hal W Hirte, Mark S Carey, et al.
Breast (Edinburgh, Scotland)|March 15, 2023
Regularly scheduled physical examinations and the detection of breast cancer recurrencesAna-Alicia Beltran-Bless, Bader Alshamsan, Mashari Jemaan Alzahrani, et al.
Clinical Genitourinary Cancer|December 8, 2014
Incomplete Cross-Resistance Between Taxanes for Advanced Urothelial Carcinoma: Implications for Clinical Practice and Trial DesignGuru Sonpavde, Gregory R Pond, Stephanie Mullane, et al.
International Journal of Radiation Oncology, Biology, Physics|January 2, 2007
Concurrent gemcitabine and radiotherapy with and without neoadjuvant gemcitabine for locally advanced unresectable or resected pancreatic cancer: a phase I-II studyAnthony Brade, James Brierley, Amit Oza, et al.
American Journal of Clinical Oncology|June 7, 2006
Natural history and chemotherapy effectiveness for advanced adenocarcinoma of the small bowel: a retrospective review of 113 casesPaula N Fishman, Gregory R Pond, Malcolm J Moore, et al.
American Journal of Clinical Oncology|December 1, 2005
A multicenter phase II study of "adjuvant" irinotecan following resection of colorectal hepatic metastasesHelen J Mackay, Kevin Billingsley, Steven Gallinger, et al.
Current Oncology (Toronto, Ont.)|August 28, 2024
HPV Self-Sampling for Cervical Cancer Screening in Under-Screened Saskatchewan Populations: A Pilot StudyErin Vink, Gabriella Antaya, Camille Hamula, et al.
Cancer|March 11, 2020
High triple-negative breast cancer prevalence and aggressive prognostic factors in Barbadian women with breast cancerShawn M Hercules, Jevon C Hercules, Amna Ansari, et al.
Cancer|February 24, 2007
Fractionated stereotactic radiotherapy for acoustic neuroma: single-institution experience at The Princess Margaret HospitalEng-Siew Koh, Barbara-Ann Millar, Cynthia Ménard, et al.
Pageof 26

Showing results (151-160 of 255) with videos related to

Sort By:
Pageof 26
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2005
Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: a Princess Margaret Hospital phase II consortium studySébastien J Hotte, Eric W Winquist, Elizabeth Lamont, et al.
Gynecologic Oncology|June 1, 2007
UCN-01 in combination with topotecan in patients with advanced recurrent ovarian cancer: a study of the Princess Margaret Hospital Phase II consortiumStephen Welch, Hal W Hirte, Mark S Carey, et al.
Breast (Edinburgh, Scotland)|March 15, 2023
Regularly scheduled physical examinations and the detection of breast cancer recurrencesAna-Alicia Beltran-Bless, Bader Alshamsan, Mashari Jemaan Alzahrani, et al.
Clinical Genitourinary Cancer|December 8, 2014
Incomplete Cross-Resistance Between Taxanes for Advanced Urothelial Carcinoma: Implications for Clinical Practice and Trial DesignGuru Sonpavde, Gregory R Pond, Stephanie Mullane, et al.
International Journal of Radiation Oncology, Biology, Physics|January 2, 2007
Concurrent gemcitabine and radiotherapy with and without neoadjuvant gemcitabine for locally advanced unresectable or resected pancreatic cancer: a phase I-II studyAnthony Brade, James Brierley, Amit Oza, et al.
American Journal of Clinical Oncology|June 7, 2006
Natural history and chemotherapy effectiveness for advanced adenocarcinoma of the small bowel: a retrospective review of 113 casesPaula N Fishman, Gregory R Pond, Malcolm J Moore, et al.
American Journal of Clinical Oncology|December 1, 2005
A multicenter phase II study of "adjuvant" irinotecan following resection of colorectal hepatic metastasesHelen J Mackay, Kevin Billingsley, Steven Gallinger, et al.
Current Oncology (Toronto, Ont.)|August 28, 2024
HPV Self-Sampling for Cervical Cancer Screening in Under-Screened Saskatchewan Populations: A Pilot StudyErin Vink, Gabriella Antaya, Camille Hamula, et al.
Cancer|March 11, 2020
High triple-negative breast cancer prevalence and aggressive prognostic factors in Barbadian women with breast cancerShawn M Hercules, Jevon C Hercules, Amna Ansari, et al.
Cancer|February 24, 2007
Fractionated stereotactic radiotherapy for acoustic neuroma: single-institution experience at The Princess Margaret HospitalEng-Siew Koh, Barbara-Ann Millar, Cynthia Ménard, et al.
Pageof 26